For the year ending 2025-12-31, PRLB had $21,755K increase in cash & cash equivalents over the period. $59,662K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 21,241 |
| Depreciation and amortization | 33,814 |
| Stock-based compensation expense | 15,729 |
| Deferred taxes | 2,912 |
| Interest on finance lease obligations | 20 |
| Loss on foreign currency translation | 0 |
| Loss on impairment of equipment | 0 |
| Impairments related to exit and closure of germany business | 448 |
| Gain on disposal of property and equipment | 4 |
| Other | -223 |
| Accounts receivable | 12,479 |
| Inventories | 2,113 |
| Prepaid expenses and other | -1,009 |
| Income taxes | 508 |
| Accounts payable | -333 |
| Accrued liabilities and other | 13,975 |
| Net cash provided by operating activities | 74,504 |
| Purchases of property, equipment and other capital assets | 14,842 |
| Proceeds from sales of property, equipment and other capital assets | 834 |
| Purchases of other assets and investments | 0 |
| Purchases of marketable securities | 17,015 |
| Proceeds from sales of marketable securities | 0 |
| Proceeds from maturities of marketable securities | 17,613 |
| Net cash used in investing activities | -13,410 |
| Proceeds from issuance of common stock from equity plans | 6,340 |
| Purchases of shares withheld for tax obligations | 3,434 |
| Repurchases of common stock and other | 42,963 |
| Principal repayments of finance lease obligations | 309 |
| Net cash used in financing activities | -40,366 |
| Effect of exchange rate changes on cash and cash equivalents | 1,027 |
| Net increase (decrease) in cash and cash equivalents | 21,755 |
| Cash and cash equivalents, beginning of period | 89,071 |
| Cash and cash equivalents, end of period | 110,826 |
Proto Labs Inc (PRLB)
Proto Labs Inc (PRLB)